Navigation Links
Exponent Adds $35 Million to Stock Repurchase Program
Date:6/3/2008

MENLO PARK, Calif., June 3 /PRNewswire-FirstCall/ -- Exponent, Inc. (Nasdaq: EXPO) announced today that its Board of Directors has authorized up to an additional $35,000,000 for the repurchase of Exponent's common stock in the open market or privately negotiated transactions in compliance with Securities and Exchange Commissions Rule 10b-18.

"This action reflects our confidence in the future cash flow of the Company, as well as our ongoing commitment to build long-term shareholder value," commented Michael Gaulke, Chairman and CEO.

About Exponent

Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm is best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with their new products to help prevent problems in the future. In addition, Exponent evaluates human health and environmental concerns to find cost-effective solutions.

Exponent may be reached at (888) 656-EXPO, info@exponent.com, or http://www.exponent.com.

This news release contains, and incorporates by reference, certain "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended thereto under) that are based on the beliefs
'/>"/>

SOURCE Exponent, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
2. H2Diesel Completes 3 Million Gallon Per Year Pilot Facility
3. Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million
4. CrossFire Beilstein Database Exceeds Ten Million Compounds
5. Mirus Bio Awarded Grants & Contracts of Over $5 Million
6. Carrington Completes $8 Million Financing
7. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
8. Human Genome Sciences Announces $40 Million Milestone Payment Related to Albuferon(R) Development
9. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
10. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
11. Cardinal Health Establishes $1 Million Grant Fund for Initiatives That Improve Quality, Safety of Patient Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2008)... , Monday, November 24, and Tuesd...irmont Algonquin, St. Andrews ...tps://www.atlanticabioenergy.com/ , NOTE TO ...available., , , ST.ANDREWS BY-THE-SEA, NB,...ry is rapidly changing and it is incumbent on all ...
(Date:11/19/2008)... MONTVALE, N.J., Nov. 19 /PRNewswire-FirstCall/ -...ay announced that it has submitted, and that the F...ce for its HAPTOCHEK(TM) diagnostic test kit. The... during which the FDA will determine whether the k...ry as an in vitro diagnostic. , , "We a...
(Date:11/19/2008)... KVISTGARD, Denmark, November 19 /PRNewswire-...S. authorities for another milestone payment of US...to manufacture and deliver 20,million doses of th...estone,payment was triggered by the recent submis...se II study with IMVAMUNE(R) in HIV infected subje...
(Date:11/19/2008)... TORONTO, Nov. 19 /PRNewswire-FirstCall/ - GeneNe...ping blood-based biomarker tests for the early det...ent, today announced the formation of a Canadian C...en, Jeffrey Baker, Khursheed JeeJeebhoy, Andy Smit...ical and patient adoption strategies for the Canad...
Breaking Biology Technology:Media Advisory - Atlantica BioEnergy Task Force Leaders' Roundtable 2Synvista Therapeutics Announces 510(k) Submission for Its HAPTOCHEK(TM) Test Kit 2Bavarian Nordic Receives USD 25 Million Milestone Payment After Submission of Important IMVAMUNE(R) Data to The U.S. Health Authorities 2GeneNews appoints Canadian Colorectal Cancer Advisory Board 2GeneNews appoints Canadian Colorectal Cancer Advisory Board 3
...echnology analysts, consultants and executives are...T spending will increase in the second half of 200...turnaround in IT spending for 2004. , ,Steve Harol...up said, Technology spending is showing signs of r... and over the last year Ive asked them how their b...
...n companies recently won CIO magazines CIO Award...resourcefulness regarding the use of information t...ergy, Lands End, Manpower Inc., Maysteel and Menas...st 15 issue of the magazine. Alliant Energy and Ma...he magazine says the 100 honorees were chosen this...
... funded with $4M in angel money. , ,But the angel.... Tech entrepreneurs could apply to the first netw...Dick Leazer and Terry Sivesind, and Early Stage R...) for investment consideration. At company present... looking for precisely these types of opportunitie...
... and navigating at the helm of several companies, ...hich is located in Woodridge, Ill. across from Ar...unity to fund and advance his drug discovery compa...Flavin says hell be hitting the road in the next f...ise about $30 million in funding. , ,Flavin isnt ...
Other Biology Technology:IT Spending to Increase in Second Half of 2003 2IT Spending to Increase in Second Half of 2003 3IT Spending to Increase in Second Half of 2003 4IT Spending to Increase in Second Half of 2003 5Five Wisconsin Non-Tech Companies Win IT Awards 2Five Wisconsin Non-Tech Companies Win IT Awards 3Five Wisconsin Non-Tech Companies Win IT Awards 4The State of Risk Capital in Wisconsin 2The State of Risk Capital in Wisconsin 3The State of Risk Capital in Wisconsin 4Advanced Life Sciences to Hit the Road For $30 Million in Funding 2Advanced Life Sciences to Hit the Road For $30 Million in Funding 3Advanced Life Sciences to Hit the Road For $30 Million in Funding 4
(Date:11/19/2008)... , , Two new compounds created by a University of...destroying breast cancer tumors. , Associate Pro...tion and spread of breast cancer tumors in tests o...ak up a cancer-causing protein called STAT3, and r...so far. , "The compounds are very promising," Tu...
(Date:11/18/2008)... ARLINGTON, Va., Nov. 18 /PRNewswire-FirstCall/ -...r of systems integration and professional,service...that it was part of a,team led by Science Applica...rded,a four-year, cost-plus-fixed-fee task order ...n years are exercised. With this award, the team w...
(Date:11/18/2008)... , PITTSBURGHResearchers at the University of Pit...or detecting mercury in fish and dental samples, t...t mercury contamination. The technique involves a ... it comes into contact with oxidized mercury, the ...f the Journal of the American Chemical Society . ...
(Date:11/18/2008)... , BIRMINGHAM, Ala. The University of Alabama at...h on Therapeutics (CERTs) has won a $2.2 million f...newer class of medicines called biologics. These a...e immune system of patients who have rheumatoid ar...immune disorders. , The award will allow the UAB...
Breaking Biology News(10 mins):Two new compounds show promise for eliminating breast cancer tumors 2Stanley to Continue Biometrics In-Service Engineering Support for U.S. Army 2Stanley to Continue Biometrics In-Service Engineering Support for U.S. Army 3Pitt researchers use fluorescence to develop method for detecting mercury in fish 2Musculoskeletal center wins $2.2 million for drug safety 2NAA Calls for Immediate Recall of All Mercury Containing Vaccines 13793 1NAA Calls for Immediate Recall of All Mercury Containing Vaccines 13793 2Government Assistance Linked to Better Child Development 13792 1Government Assistance Linked to Better Child Development 13792 2In Post Vioxx Era Biologics are Reviving the Arthritis Treatment Market 13790 1In Post Vioxx Era Biologics are Reviving the Arthritis Treatment Market 13790 2Universal Health Realty Income Trust Announces Dividend 13788 1
...ts have discovered that a sex gene responsible for...o produced by the brain region targeted by Parkins... Current Biology, the new research may explain why...rder, which afflicts roughly 1 million Americans. ...son,s disease than women," said Dr. Eric Vilain, a...
...y that could greatly accelerate the search for gen... Duke University research team has found that the ... for testing human genes implicated in heart disea..., because the entire genome of the fruit fly is we... to systemically screen genes to identify potentia...
...st effective chemotherapy drugs against cancer is ...srupts repair. However, it also kills healthy tiss... or cisplatin analogs in attempts to find treatmen...velopment is light activated drugs, or photodynami...logy research team that has been working on both n...
...nt new study forthcoming from The American Natural...ked a colony of mute swans for more than two decad...: whether the number of eggs laid by a female bird...th natural selection. , "Extensive debate in the l...oes a population,s average clutch size differ from...
Other Biology News:UCLA scientists find male gene in brain area targeted by Parkinson's 2Fruit fly's beating heart helps identify human heart disease genes 2Fruit fly's beating heart helps identify human heart disease genes 3Light activated anticancer drug targeted to DNA using cisplatin like sub-units 2
Goat polyclonal to FbxL7 The F box, named after cyclin F in which it was originally observed, is an approximately 40-amino acid motif that binds SKP1. F-box proteins are components of modular E3 ubi
Goat polyclonal to XAGE1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: CGFGFRRQGEDNT, corresponding to C terminal amino acids 149-160 of Human XAGE1 Entrez Gene ID: 9
Synaptotagmin, phosphoSer309
anti-phospho-PTEN (Ser385) Immunogen: Peptide corresponding to amino acid region encompassing the human, mouse, and rat phospho-PTEN (Ser385), Accession Number: NM_000314 Quality Assurance
Biology Products: